MSB 2.08% 94.0¢ mesoblast limited

Ann: 83% Survival in COVID-19 ARDS Patients with Remestemcel-L, page-386

  1. 12,517 Posts.
    lightbulb Created with Sketch. 3391
    Let the shorters short
    Let the naysayers critique

    Just sit back and smile!

    It doesn't matter now, the "story" is unfolding and the SP will follow

    Consider this day1 of the "Global" Mesoblast behemoth

    That "lucky" company with years of science behind it
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
94.0¢
Change
-0.020(2.08%)
Mkt cap ! $1.073B
Open High Low Value Volume
95.5¢ 97.0¢ 93.5¢ $1.424M 1.507M

Buyers (Bids)

No. Vol. Price($)
8 29390 93.5¢
 

Sellers (Offers)

Price($) Vol. No.
94.5¢ 14089 2
View Market Depth
Last trade - 16.10pm 13/09/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.